Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | 693,10 € | 755,83 € | 9,05 % |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | 378,90 € | 382,71 € | 1,00 % |
| Alnylam Pharmace. | 35 | 0 | 3 | 0 | 135,80 € | 236,30 € | 74,00 % |
| Regeneron Pharmaceuticals Inc. | 32 | 1 | 6 | 1 | 847,80 € | 954,29 € | 12,56 % |
| Johnson & Johnson | 32 | 1 | 2 | 0 | 137,82 € | 196,74 € | 42,75 % |
| Pfizer Inc. | 30 | 4 | 3 | 1 | 24,41 € | 41,29 € | 69,14 % |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | 117,60 € | 124,92 € | 6,22 % |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | 0,41 € | - | - |
| Amgen Inc. | 23 | 0 | 3 | 0 | 252,05 € | 293,65 € | 16,50 % |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | 134,95 € | 137,63 € | 1,99 % |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | 61,00 € | 86,72 € | 42,16 % |
| Intra-Cellular Therapies Inc. | 22 | 0 | 7 | 0 | 68,50 € | 79,29 € | 15,75 % |
| BioMarin Pharmaceutical Inc. | 18 | 0 | 0 | 0 | 87,04 € | 102,48 € | 17,73 % |
| Sutro Biopharma Inc | 18 | 0 | 7 | 0 | 3,52 € | 11,05 € | 213,88 % |
| AbbVie Inc. | 18 | 1 | 2 | 1 | 157,00 € | 175,79 € | 11,97 % |
| Natural Alternat. | 18 | 1 | 1 | 0 | 5,80 € | - | - |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | 118,50 € | 130,44 € | 10,07 % |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | 13,44 € | 26,00 € | 93,50 % |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | 11,06 € | 22,78 € | 105,92 % |
| Abbott Laboratories | 16 | 0 | 4 | 0 | 99,68 € | 116,81 € | 17,18 % |
| Krystal Biotech | 16 | 0 | 3 | 0 | 150,75 € | 173,22 € | 14,90 % |
| Icon plc | 15 | 0 | 3 | 0 | 288,40 € | 318,32 € | 10,37 % |
| Exelixis Inc. | 15 | 0 | 0 | 0 | 21,65 € | 26,01 € | 20,12 % |
| United Therapeutics | 15 | 0 | 0 | 0 | 219,10 € | 289,92 € | 32,32 % |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 0 | 10,60 € | 21,39 € | 101,82 % |